ZHIYONG DING to Mice, SCID
This is a "connection" page, showing publications ZHIYONG DING has written about Mice, SCID.
Connection Strength
0.048
-
Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy. Cancer Cell. 2019 06 10; 35(6):851-867.e7.
Score: 0.031
-
Vimentin is a novel AKT1 target mediating motility and invasion. Oncogene. 2011 Jan 27; 30(4):457-70.
Score: 0.017